Major Depressive Disorder Market is expected to reach US$ 14.57 billion by 2033 | Major players - Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Viatris Inc.

Market Size and Growth:

The Global Major Depressive Disorder Market size reached US$ 6.84 billion in 2024 and is expected to reach US$ 14.57 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.

The Major Depressive Disorder Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/major-depressive-disorder-market?sz

The Major Depressive Disorder (MDD) Market encompasses the development, production, and commercialization of therapies, including antidepressants, psychotherapy, and emerging treatments, aimed at managing MDD. It addresses the growing prevalence of depression worldwide, focusing on improving patient outcomes, reducing symptom severity, and enhancing quality of life. Market growth is driven by rising awareness, innovation, and healthcare accessibility.

Recent Key Developments of United States:

✅ December 2025: Johnson & Johnson launched a digital therapeutics platform integrated with vortioxetine, combining AI-driven therapy with pharmacotherapy for better adherence. Real-world evidence from pilot studies indicated 30% improvement in patient outcomes. Regulatory nods supported broader reimbursement coverage.

✅ November 2025: A pivotal Phase III trial for a novel multimodal antidepressant targeting neuroinflammation met primary endpoints, reducing Hamilton Depression Rating Scale scores by 45% versus placebo. Partnerships with biotech firms accelerated its pathway to market entry. This development promised faster onset compared to SSRIs.

✅ October 2025: The FDA expanded approval for esketamine nasal spray to include maintenance treatment in adults with treatment-resistant depression, enhancing long-term management options. Clinical trials showed sustained remission rates over six months in diverse patient groups. This addressed gaps in chronic MDD care amid rising demand.

Recent Key Developments of Japan:

✅ December 2025: Shionogi received full approval to manufacture and market ZURZUVAE® Capsules 30 mg, a rapid-acting antidepressant for postpartum-onset MDD. This filled unmet needs in maternal mental health, with launch targeted for early 2026. Regional forecasts predicted accelerated market expansion through personalized care models.​

✅ November 2025: Shionogi initiated post-marketing surveillance for a new serotonin modulator, reporting low adverse events in elderly patients amid Japan's aging demographic. Sales projections indicated 15% market share growth. Emphasis on telemedicine delivery boosted rural access.

✅ October 2025: The Ministry of Health approved brexpiprazole augmentation therapy for first-line MDD treatment, based on local trials demonstrating superior efficacy in Asian populations. Market uptake focused on Kanto region's clinics. This aligned with national mental health integration initiatives.

List of the Key Players in the Major Depressive Disorder Market:

Pfizer Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Sun Pharmaceutical Industries Ltd.
Eli Lilly and Company
Otsuka Pharmaceutical Co., Ltd.
Aurobindo Pharma Limited
Sanofi
Biogen

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/major-depressive-disorder-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Major Depressive Disorder Market:

By Type: Seasonal Affective Disorder, Prenatal Depression, Postpartum Depression, Atypical Depression.

By Treatment Type: Antidepressants, Psychotherapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Vagus Nerve Stimulation (VNS), Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=major-depressive-disorder-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Major Depressive Disorder market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Major Depressive Disorder Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Major Depressive Disorder market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Major Depressive Disorder Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Major Depressive Disorder Market in 2025?
◆ What is the projected growth rate of the Major Depressive Disorder Market through 2033?
◆ Who are the key players in the Major Depressive Disorder Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.